Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Biotech
Amgen posts ph. 3 Sjögren’s data ahead of Novartis showdown
Amgen shared data from a phase 3 Sjögren’s disease trial that dazzled analysts, digging into the details that could shape its showdown with Novartis.
Nick Paul Taylor
Nov 11, 2026 8:00am
Artiva lays off staff after deaths, durability sink cell therapy
Oct 27, 2026 8:40am
Nuvig halts development of lead drug for rare autoimmune disease
Oct 6, 2026 2:48pm
Novartis pens $7.8B deal for Abogen's in vivo autoimmune TCE
Oct 2, 2026 4:24am
ai3Bio buzzing with $48M for STING pathway targeting pipeline
Sep 29, 2026 9:00am
Amgen fusion protein eases Sjögren's severity in ph. 3 win
Sep 22, 2026 10:20am